Bringing the power of DNA synthesis to bear in the field of synthetic biology

Synthetic biology offers transformative potential in applications ranging from biosensor design to novel therapeutic R&D. David McCall, Senior Editor, BioInsights, speaks to Paul Freemont, Head of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, about the recent advancements and future prospects in synthetic biology, particularly concerning the development of biofoundries and related work in scaling and automating DNA synthesis.